Minoryx announces dosing of the first patient with leriglitazone in the phase 2a study in Rett’s Syndrome (TREE study)

by Ysios Capital

TREE is a phase 2a clinical study assessing the safety and efficacy of lead candidate leriglitazone, a novel, brain-penetrant and selective PPAR gamma agonist, to treat patients with Rett syndrome.

Read more

Mejorar la calidad del sueño para un envejecimiento cerebral saludable

by Fundación Pasqual Maragall

Una escasa calidad del sueño comporta un descanso inadecuado y la Dra. Fernández Arcos advierte de que puede tener un impacto significativo en la salud cerebral, favoreciendo procesos neuroinflamato...

Read more

Un estudio desvela la composición de la microbiota del mosquito Culex perexiguus, principal vector del virus del Nilo

by Professional Newco

El equipo ha realizado la primera caracterización de la microbiota bacteriana de la especie de mosquito Culex perexiguus, principal vector del virus del Nilo Occidental en Andalucía. El estudio expl...

Read more

Atrys Chile and Interclínica launch a new telemedicine-based care model to reduce stroke response time

by Atrys Health

The new model seeks to alleviate the lack of specialized neurologists in remote regions in Chile, connecting Atrys specialists with Interclinica treating physicians in real time, allowing for a more a...

Read more

Nace Albor Biotech, la ‘spin-off’ de la USC que ejercerá de partner estratégico en el desarrollo de soluciones para combatir las patologías asociadas al síndrome metabólico

by Albor Biotech

La nueva compañía estará enfocada en las fases iniciales de desarrollo y validación preclínica de soluciones terapéuticas (CRO) dirigidas al área del metabolismo. Afrontará, según sus fundado...

Read more

Oryzon announces publication of study on Phelan-McDermid Syndrome (PMS) patients, a form of autism, paving the way for a novel personalized medicine approach with vafidemstat

by Oryzon Genomics

Study provides clinical scales and thresholds for patient selection in future clinical trials, based on aggressiveness, cognition, and behavioral traits

Read more

An IDIBAPS-Hospital Clínic team identifies a key factor in the appearance of fibrosis in the liver

by Fundació Clínic per a la Recerca Biomèdica

The study identifies RORA as a protector against fibrosis in the liver, heart and kidneys. This protein may prevent the overactivation of hepatic stellate cells, and consequently, fibrosis. The result...

Read more

New advances in the prevention of oral human papillomavirus and pharyngeal cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

It has been published the PROGRESS study results, the first to robustly describe the prevalence of oral HPV infection and associated factors in Europe and the United States. This study has carried out...

Read more

Researchers from the ibs.GRANADA discover the impact of genetics on hereditary arrhythmias

by Instituto de Investigación Biosanitaria - Ibs Granada

The study, published in Circulation: Arrhythmia and Electrophysiology, reveals how certain genetic mutations influence the risk and manifestation of inherited ventricular arrhythmias, affecting the he...

Read more

First European Clinical Guideline for Alport Syndrome Management Published

by Hospital de la Santa Creu i Sant Pau

The Sant Pau Research Institute (IR Sant Pau) and the Fundació Puigvert, a national and European reference centre in the diagnosis and treatment of rare renal and urogenital diseases, have participat...

Read more

CNIO will help building Europe’s largest DNA catalogue

by CNIO - Centro Nacional de Investigaciones Oncológicas

The European project Genome of Europe (GoE) will generate the most comprehensive genetic database of the European population to date, sequencing 100,000 genomes representing people across the continen...

Read more

The Spanish Association Against Cancer allocates more than €2.4 M to research at IRB Barcelona

by IRB Barcelona - Instituto de Investigación Biomédica

Five projects at IRB Barcelona receive new funding from the Spanish Association Against Cancer. This support allows IRB Barcelona to advance in key research into metastasis and innovative drug develop...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream